spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Kennedy names his deputy Jim O’Neill as interim US CDC chief after Monarez firing

U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. has named his deputy, Jim O’Neill, as acting director at the Centers for Disease Control and Prevention after ousting the former director less than a month into her tenure.

President Donald Trumpfired on Wednesday CDC Director Susan Monarez after she resisted changes to vaccine policy advanced by Kennedy that she believed contradicted scientific evidence, further destabilizing the already embattled agency.

“Together, we will rebuild this institution into what it was always meant to be: a guardian of America’s health and security,” Kennedy wrote on Thursday in a memo to CDC staff seen by Reuters. “To help advance this mission, I am pleased to announce that Deputy Secretary of Health and Human Services Jim O’Neill is now also serving as Acting Director of the CDC.”

Monarez’s firing triggered the resignations of four senior CDC officials who cited anti-vaccine policies and misinformation pushed by Kennedy and his team.

The CDC has faced mounting challenges under Kennedy’s leadership, including a shooting at its Atlanta headquarters earlier this month. The union representing CDC workers said the incident “compounds months of mistreatment, neglect, and vilification that CDC staff have endured.”

The White House sought to cut the agency’s budget by almost $3.6 billion, leaving it with a $4 billion 2026 budget, and Kennedy announced a layoff plan earlier this year that cut 2,400 CDC employees, though some 700 were rehired.

O’Neill, prior to his confirmation as Kennedy’s second in command, served as a health policy adviser with ties to several healthcare companies.

He also managed one of tech billionaire and Trump-backer Peter Thiel’s venture capital firms, Mithril Capital Management, from 2012 to 2019. O’Neill also served as chief executive of his philanthropic Thiel Foundation and as a managing director at Thiel Capital.

Hot this week

Bayer CEO: overhaul is leading to pharma pipeline boost

Bayer Chief Executive Bill Anderson said the company is...

Roche shares rise as company advances experimental obesity drug to late-stage trial

Shares in Roche Holding rose around 2% on Monday,...

EXPERIMENTAL ANTIBIOTIC SHOWS PROMISE AGAINST SUPERBUGS

A synthetic antibiotic is showing potent activity against some...

New US Global Health Plan Prioritizes Drugs, Recipients’ Self-Reliance

The United States will prioritize frontline health supplies, staff,...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img